Literature DB >> 33165507

Misguided Use of Hydroxychloroquine for COVID-19: The Infusion of Politics Into Science.

Michael S Saag1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33165507     DOI: 10.1001/jama.2020.22389

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

Review 1.  COVID-19-from emerging global threat to ongoing pandemic crisis.

Authors:  Karen B Brust; Vinayika Papineni; Cristie Columbus; Alejandro C Arroliga
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-09

2.  Experience of Community Neurologists Providing Care for Patients With Neurodegenerative Illness During the COVID-19 Pandemic.

Authors:  Roman Ayele; Zachary A Macchi; Megan Dini; Meredith Bock; Maya Katz; Steven Z Pantilat; Jacqueline Jones; Benzi M Kluger
Journal:  Neurology       Date:  2021-06-14       Impact factor: 11.800

3.  Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies.

Authors:  Kayte Spector-Bagdady; Holly Fernandez Lynch; Barbara E Bierer; Luke Gelinas; Sara Chandros Hull; David Magnus; Michelle N Meyer; Richard R Sharp; Jeremy Sugarman; Benjamin S Wilfond; Ruqaiijah Yearby; Seema Mohapatra
Journal:  Hastings Cent Rep       Date:  2021-12-15       Impact factor: 4.298

4.  Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.

Authors:  Koushik Mondal; Hunter Porter; Jerome Cole; Hemang K Pandya; Sandip K Basu; Sufiya Khanam; Chi-Yang Chiu; Vinay Shah; Daniel J Stephenson; Charles E Chalfant; Nawajes Mandal
Journal:  Mol Neurobiol       Date:  2022-04-15       Impact factor: 5.682

5.  Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor.

Authors:  Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2022-04-28       Impact factor: 10.614

6.  Making trials part of good clinical care: lessons from the RECOVERY trial.

Authors:  Guilherme Pessoa-Amorim; Mark Campbell; Lucy Fletcher; Peter Horby; Martin Landray; Marion Mafham; Richard Haynes
Journal:  Future Healthc J       Date:  2021-07

7.  Retracted papers on SARS-CoV-2 and COVID-19.

Authors:  Andrea Cortegiani; Giulia Catalisano; Mariachiara Ippolito; Antonino Giarratano; Anthony R Absalom; Sharon Einav
Journal:  Br J Anaesth       Date:  2021-01-19       Impact factor: 9.166

8.  WHO guidance on ethics in outbreaks and the COVID-19 pandemic: a critical appraisal.

Authors:  Abha Saxena; Paul André Bouvier; Ehsan Shamsi-Gooshki; Johannes Köhler; Lisa J Schwartz
Journal:  J Med Ethics       Date:  2021-03-31       Impact factor: 2.903

9.  Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells.

Authors:  Ahmad Besaratinia; Andrew W Caliri; Stella Tommasi
Journal:  DNA Repair (Amst)       Date:  2021-07-16

Review 10.  Cyclodextrins in the antiviral therapy.

Authors:  László Jicsinszky; Katia Martina; Giancarlo Cravotto
Journal:  J Drug Deliv Sci Technol       Date:  2021-05-20       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.